0 CHECKOUT

PRODUCT FILTERS

REGION

623
256
255
213
213

COUNTRY

202
62
44
36
36

PRICE

152
359
807
1,864

PUBLISHED

82
434
738
1,864

PRODUCT TYPE

1,366
328
144
17
8
1

Central Nervous System Drugs

In 2012 major changes might revolutionize the treatment of multiple sclerosis, as Gilenya, the first novel drug in five years, will be joined by three new products: BG-12, Aubagio, and Lemtrada. Recent exciting developments in drug discovery might also enhance the hopes of those fighting against Alzheimer.

Great commercial and scientific opportunities are to be found in similar battles against a range of diseases and neurodegenerative disorders, e.g. Parkinson’s disease, schizophrenia, migraine, insomnia, epilepsy, etc.

A wide selection of industry reports, scientific journals and academic textbooks in this section allow readers to explore every conceivable facet of this industry, such as market trends, industry forecasts, new drugs in development, the latest research & development, patent applications, and licensing strategies.

Key players featured in our publications include Biogen Idec, Sanofi, Genzyme, and many more. Show Less
Read more

Neuroprotection - Drugs, Markets and Companies

This report describes the role of neuroprotection in acute disorders such as stroke and injuries of the nervous system as well as in chronic diseases such as neurodegenerative disorders because many...

Published:  April 2016
Price:  From

Spinal Muscular Atrophy Market - Pipeline Assessment, Size, Growth, Trends, and Forecast 2015 - 2023

"Pipeline analysis of spinal muscular atrophy (SMA) market report provides with comprehensive analysis of drugs in clinical trials for treatment for spinal muscular atrophy. The report provides insights...

Published:  October 2015
Price:  From

Alzheimer Disease - New Drugs, Markets and Companies

Alzheimer's disease remains a challenge in management. With nearly 8 million sufferers from this condition in the seven major markets of the world and anticipated increases in the future. Considerable...

Published:  April 2016
Price:  From

Global Market Study on Osteoporosis Drugs: Asia Pacific to Witness Highest Growth by 2022

Osteoporosis is a progressive, skeletal disease, leading to fragile and abnormally porous bones. It is characterized by decrease in bone density, strength, and micro-architectural deterioration of bone...

Published:  June 2015
Price:  From

Huntington's Disease Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for Huntington's Disease Therapeutics in US$ Million. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual...

Published:  March 2015
Price:  From

Neurotech Industry 2015-2016 Report: Drugs, Biologics, Stem Cells, Devices and Diagnostics for the Brain and Nervous System

Now in its 11th year, The Neurotechnology Industry 2015-2016 Report is an expanded and updated 650 page report of brain and nervous system markets and treatments. It is the only publication to provide...

Published:  September 2015
Price:  From

Global Duchenne Muscular Dystrophy Drugs Market 2015-2019

About Duchenne muscular dystrophy Duchenne muscular dystrophy is an X-linked disease, which generally affects the male population. It is characterized by progressive muscle degeneration and weakness....

Published:  August 2015
Price:  From

India Neuropsychiatry (Drugs and Devices) Market: Trends, Opportunities and Forecasts (2015-2020F)

'India Neuropsychiatry (Drugs and Devices) Market: Trends, Opportunities and Forecasts (2015-2020F) - (Segmentation By Value and Volume, By Region, Diagnosis and Treatment Devices, Value Chain, Key...

Published:  December 2015
Price:  From

Global Alzheimer’s Drug Market: Trends, Opportunities and Forecasts (2015-2020) (By Type - Imaging, Therapeutics, Diagnostics, Biomarkers; By Age: <65 years, >65 years age; By Region; Global Dementia Market)

The Global Alzheimer’s Market is growing at a moderate rate over last five years on account of rising expenditure on health care especially neurological disorders among ageing population and escalating...

Published:  December 2015
Price:  From

Global Sleeping Aids Market Size, Share, Development, Growth and Demand Forecast to 2020 - Industry Insights by Sleep Disorders, Product, by Medication

'Global Sleeping Aids Market Size, Share, Development, Growth and Demand Forecast to 2020 - Industry Insights by Sleep Disorders (Insomnia, Sleep Apnea, Restless Legs Syndrome, Narcolepsy, Sleep Walking...

Published:  October 2015
Price:  From

Alzheimer'S Disease: Pharmacuetical Drugs Vs. Medicinal Plants - Markets, Competitors and Opportunities: 2015-2020 Analysis and Forecasts

The objective of this report is to provide a detailed analysis of Alzheimer’s disease (AD) and the pharmaceutical drugs and medicinal plants used to treat and prevent it. It also provides an overview...

Published:  July 2015
Price:  From

Epilepsy Drugs Market in Europe - Market Analysis 2015-2019

About epilepsy Epilepsy refers to a spectrum of brain disorders manifested by benign to severe, disabling, and life-threatening symptoms. It is caused by factors ranging from brain malformations and...

Published:  September 2015
Price:  From

Osteoporosis Drugs Market in BRIC Nations 2015-2019

About osteoporosis Osteoporosis, or porous bone, is a disease characterised by low bone density and structural deterioration of bone tissue, leading to fragile bones. This increases the risk of fractures....

Published:  September 2015
Price:  From

Global Migraine Drugs Market 2015-2019

About Migraine Migraine is a complex neurological medicial condition characterized by a severe headache. The headache is often accompanied by nausea, vomiting, and extreme sensitivity to light and sound....

Published:  February 2015
Price:  From

Epilepsy Therapeutics Market in the APAC Region 2015-2019

About Epilepsy Therapeutics Epilepsy is a spectrum of brain disorders varying from benign to severe, disabling, and life-threatening symptoms. It is caused by various factors ranging from brain malformations...

Published:  December 2014
Price:  From

Global Osteoporosis Drugs Market 2015-2019

About osteoporosis Osteoporosis, or porous bone, is a disease characterized by low bone density and structural deterioration of bone tissue, leading to fragile bones. As bones becomes fragile, risk...

Published:  May 2015
Price:  From

CNS Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for CNS Therapeutics in US$ Million by the following Product Groups: Anti-Alzheimer's, Anti-Parkinson's, Anti-Epilepsy, Pain Management, Anti-Psychotics, Anti-Depressants,...

Published:  February 2015
Price:  From

Global Multiple Sclerosis Drugs Market 2014-2018

About Multiple Sclerosis and Disease Types Multiple sclerosis is a chronic, inflammatory medical condition that results in demyelination, axonal transection, and neurodegeneration. The myelin sheath...

Published:  August 2014
Price:  From

Global Huntington's Disease Therapeutics Market 2014-2018

About Huntington's Disease Huntington's disease is a progressive neurodegenerative disorder that can be inherited from one generation to another as an autosomal dominant trait. It arises due to genetically...

Published:  October 2014
Price:  From

Global Alzheimer's Drugs Market 2014-2018

Alzheimer's disease is a progressive, irreversible degeneration of the brain that disrupts the thinking, language, behavioral and cognitive skills of a person. AD is more prevalent in people aged 65...

Published:  June 2014
Price:  From
Loading Indicator

Our Clients